Literature DB >> 30166962

Emerging Therapies Toward a Functional Cure for Hepatitis B Virus Infection.

W Ray Kim1.   

Abstract

Entities:  

Year:  2018        PMID： 30166962      PMCID： PMC6111501     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

Review 1.  Hepatitis B cure: From discovery to regulatory approval.

Authors:  Anna S Lok; Fabien Zoulim; Geoffrey Dusheiko; Marc G Ghany
Journal:  J Hepatol       Date:  2017-08-01       Impact factor: 25.083

Review 2.  New treatments to reach functional cure: Rationale and challenges for emerging immune-based therapies.

Authors:  Adam J Gehring
Journal:  Best Pract Res Clin Gastroenterol       Date:  2017-05-25       Impact factor: 3.043

Review 3.  Drugs in Development for Hepatitis B.

Authors:  Altaf Dawood; Syed Abdul Basit; Mahendran Jayaraj; Robert G Gish
Journal:  Drugs       Date:  2017-08       Impact factor: 9.546

Review 4.  Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?

Authors:  Sonia Alonso; Adriana-René Guerra; Lourdes Carreira; Juan-Ángel Ferrer; María-Luisa Gutiérrez; Conrado M Fernandez-Rodriguez
Journal:  BMC Gastroenterol       Date:  2017-12-21       Impact factor: 3.067
  4 in total
  8 in total

Review 1.  HBV replication inhibitors.

Authors:  Claire Pierra Rouviere; Cyril B Dousson; John E Tavis
Journal:  Antiviral Res       Date:  2020-05-05       Impact factor: 5.970

2.  Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses In Vitro and in Humanized Mice.

Authors:  Franck Amblard; Sebastien Boucle; Leda Bassit; Bryan Cox; Ozkan Sari; Sijia Tao; Zhe Chen; Tugba Ozturk; Kiran Verma; Olivia Russell; Virgile Rat; Hugues de Rocquigny; Oriane Fiquet; Maud Boussand; James Di Santo; Helene Strick-Marchand; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

Review 3.  Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure.

Authors:  Andrew Vaillant
Journal:  Viruses       Date:  2021-04-23       Impact factor: 5.048

4.  Preferences of Patients with Chronic Hepatitis B - A Discrete Choice Experiment on the Acceptability of Functional Cure.

Authors:  Fraence Hardtstock; Urbano Sbarigia; Zeki Kocaata; Thomas Wilke; Shirley V Sylvester
Journal:  Patient Prefer Adherence       Date:  2020-03-19       Impact factor: 2.711

5.  Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator.

Authors:  Selwyn J Hurwitz; Noreen McBrearty; Alla Arzumanyan; Eugene Bichenkov; Sijia Tao; Leda Bassit; Zhe Chen; James J Kohler; Franck Amblard; Mark A Feitelson; Raymond F Schinazi
Journal:  Viruses       Date:  2021-01-15       Impact factor: 5.048

6.  Mechanism of action of hepatitis B virus S antigen transport-inhibiting oligonucleotide polymer, STOPS, molecules.

Authors:  C Cheng Kao; Yuchun Nie; Suping Ren; N Tilani T S De Costa; Rajendra K Pandey; Jin Hong; David B Smith; Julian A Symons; Leonid Beigelman; Lawrence M Blatt
Journal:  Mol Ther Nucleic Acids       Date:  2021-12-11       Impact factor: 8.886

7.  Inspiration to mRNA-based COVID-19 vaccination: Serious adverse case reports with hepatitis B vaccine in real-world.

Authors:  Jinmiao Lu; Xunjie Zhang; Hong Xu; Zhiping Li
Journal:  Front Pediatr       Date:  2022-09-23       Impact factor: 3.569

Review 8.  Clinical Implications of Hepatitis B Virus RNA and Covalently Closed Circular DNA in Monitoring Patients with Chronic Hepatitis B Today with a Gaze into the Future: The Field Is Unprepared for a Sterilizing Cure.

Authors:  Anastasiya Kostyusheva; Dmitry Kostyushev; Sergey Brezgin; Elena Volchkova; Vladimir Chulanov
Journal:  Genes (Basel)       Date:  2018-10-05       Impact factor: 4.096
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.